HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement encouraging the Drug Enforcement Administration (DEA) to take critical steps to ease current shortages of injectable opioids:
“Hospitals and other healthcare providers are currently experiencing critical shortages of a number of injectable opioid medications – including morphine, hydromorphone, and fentanyl – that are an essential element of treatment for post – surgical and medical pain management. Without the necessary opioids available, many medical procedures would have to be postponed or cancelled, jeopardizing the wellbeing of patients across the country. Controlling narcotics use – particularly outpatient prescription opioid abuse – remains a public health priority that HSCA supports.”
Related Posts
HSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
August 21, 2018
Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association...
HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
June 7, 2018
We, the undersigned, commend you for your leadership and commitment to reducing...
HSCA Comments on FDA Bulk Substance Guidance
May 25, 2018
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Comments on DEA Proposed Rule on Opioid Production Limits
May 4, 2018
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...